149 related articles for article (PubMed ID: 15764763)
21. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
22. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
23. The influence of selective pulmonary perfusion on the inflammatory response and clinical outcome of patients with chronic obstructive pulmonary disease undergoing cardiopulmonary bypass.
Kiessling AH; Guo FW; Gökdemir Y; Thudt M; Reyher C; Scherer M; Beiras-Fernandez A; Moritz A
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):732-9. PubMed ID: 24632426
[TBL] [Abstract][Full Text] [Related]
24. Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia.
Hochberg MC; Arnold CM; Hogans BB; Spivak JL
Arthritis Rheum; 1988 Oct; 31(10):1318-21. PubMed ID: 3178910
[TBL] [Abstract][Full Text] [Related]
25. Correlation between serum biomarkers and BODE index in patients with stable COPD.
Liu SF; Chin CH; Wang CC; Lin MC
Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary function testing after stereotactic body radiotherapy to the lung.
Bishawi M; Kim B; Moore WH; Bilfinger TV
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e107-10. PubMed ID: 21470798
[TBL] [Abstract][Full Text] [Related]
27. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure.
Kourea K; Parissis JT; Farmakis D; Panou F; Paraskevaidis I; Venetsanou K; Filippatos G; Kremastinos DT
Atherosclerosis; 2008 Jul; 199(1):215-21. PubMed ID: 17991471
[TBL] [Abstract][Full Text] [Related]
28. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion.
Berton DC; Silveira L; Da Costa CC; De Souza RM; Winter CD; Zimermann Teixeira PJ
Arch Phys Med Rehabil; 2013 Aug; 94(8):1607-14. PubMed ID: 23416765
[TBL] [Abstract][Full Text] [Related]
31. Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease.
Kim SJ; Yoon DW; Lee EJ; Hur GY; Jung KH; Lee SY; Lee SY; Shin C; Shim JJ; In KH; Kang KH; Yoo SH; Kim JH
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1265-70, i. PubMed ID: 21943856
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin response to critical illness.
Krafte-Jacobs B; Levetown ML; Bray GL; Ruttimann UE; Pollack MM
Crit Care Med; 1994 May; 22(5):821-6. PubMed ID: 8181291
[TBL] [Abstract][Full Text] [Related]
33. [Incidence of hospitalizations among chronic obstructive pulmonary disease (COPD) patients with anemia].
Frank Y; Regev A; Novack V; Avnon L; Avriel A; Shimonovich F; Heimer D; Maimon N
Harefuah; 2012 Apr; 151(4):211-5, 254. PubMed ID: 22616148
[TBL] [Abstract][Full Text] [Related]
34. High prevalence of COPD in atherosclerosis patients.
Tuleta I; Farrag T; Busse L; Pizarro C; Schaefer C; Pingel S; Nickenig G; Skowasch D; Schahab N
Int J Chron Obstruct Pulmon Dis; 2017; 12():3047-3053. PubMed ID: 29089753
[TBL] [Abstract][Full Text] [Related]
35. [The study of inflammatory mediators and pulmonary ventilatory capacity in patients with chronic obstructive pulmonary disease].
He B; Zhao MW; Wang YZ; Liu XF; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):22-5. PubMed ID: 12775264
[TBL] [Abstract][Full Text] [Related]
36. Circulating monocytes from healthy individuals and COPD patients.
Aldonyte R; Jansson L; Piitulainen E; Janciauskiene S
Respir Res; 2003; 4(1):11. PubMed ID: 14624669
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
38. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease.
Krishnan G; Grant BJ; Muti PC; Mishra A; Ochs-Balcom HM; Freudenheim JL; Trevisan M; Schünemann HJ
BMC Pulm Med; 2006 Sep; 6():23. PubMed ID: 16953872
[TBL] [Abstract][Full Text] [Related]
39. Associations between BODE index and systemic inflammatory biomarkers in COPD.
Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment.
Perng DW; Huang HY; Chen HM; Lee YC; Perng RP
Chest; 2004 Aug; 126(2):375-81. PubMed ID: 15302720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
